Jul 20 2012
GlobalPost's "Global Pulse" blog features an interview with Zeda Rosenberg, CEO of the International Partnership for Microbicides (IPM), in which she discusses a study of a vaginal ring containing the antiretroviral (ARV) dapivirine. The study, which "has been launched in Africa, mark[s] a step forward in the development of HIV protection for and under control of women," the blog notes. Rosenberg addresses the importance of finding a female-controlled HIV prevention option, why women are more susceptible to HIV infection, and her motivation for becoming involved in HIV research, among other issues, according to the blog (Judem, 7/18).
 This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|
Do you wear makeup while you exercise? New research reveals the effects on skin and pores